Tuesday, May 10, 2011

11th May 2011 Ranbaxy Laboratories looks good

11th May 2011 (Ranbaxy Laboratories looks good: Astroprofit)


Today’s transit: Moon is transiting over the Cancer sign till 9:15 Am thereafter over the Leo sign. Jupiter, Exalted Sun, Venus, Mercury and owned sign Mars is posited in Aries sign. Retrograded Saturn is in Virgo sign. Rahu is in Scorpio sign. Ketu is posited in Taurus sign.

Today’s Panchang:

Samvat: 2067

Lunar Month: Vaishakha

Shukla Paksha

Wednesday

Tithi: Ashtami

Nakshatra: Ashlesha

Yoga: Vriddhi

Karana: Bava

Rahu Kala: 12:00 to 13:30 (In LMT, for all places on earth)

India has completed 63 years of freedom. According to 64th year of VASHA-KUNDLI of INDIA Muntha is posited in 3rd house which is good. But at present the Dasha of Rahu is running till 11th May April 2011. Rahu is posited in 7th house with and is aspect by Mars. (We are using Parashari aspect rather Tajik in varshphal)

NIFTY LEVELS

Nifty (5541.25)

Support @ 5510-5470-5440

Resistance @ 5590-5610-5660

Strategy/Trend: Volatile

Stock to Watch

Ranbaxy Laboratories Ltd. incorporated on dated 16th June 1961. Today Moon is transiting over the 2nd house from the natal Moon and other planetary combinations are indicating some upside in intraday or coming days.

Ranbaxy Lab (CMP 450.35)

Stop Loss: 434-418

Target: 461-471

Strategy/Trend: Upside

Yesterday Performance: Adani Ent. Made a high of 626.80 and Bank of India made a high of 414.90 both the calls are still open.

Disclaimer: - The predictions made herein are for information purposes and are not recommendations to any person to buy or sell any securities. We only use astrological analysis, so target are not based on any technical or fundamental analysis but only on the experience of an astrologer. Its accuracy and completeness are not guaranteed. The information provided herein is not to be construed as an offer to buy or sell securities of any kind. The Astrologer and the company do not accept any liability for the use of this column. Readers of this column who buy or sell securities based on the information in this column are solely responsible for their actions. And author won't be liable or responsible for any legal or financial losses made by anyone.


No comments: